China's Leading Medical Consumables Device Maker Weigao Plans New Share Offering In Hong Kong; JV With MNCs To Explore New Landscape
This article was originally published in PharmAsia News
SHANGHAI - Weihai-based Shandong Weigao Group Medical Polymer Company Limited, the leading Chinese medical consumables manufacturer and Medtronic Inc., which holds 15% of its total stake, is planning a secondary offering of 85.6 million H shares in Hong Kong to raise roughly HK$1.736 billion ($223 million) to expand its production capability and fund potential merger and acquisitions
You may also be interested in...
China begins device tender process, and with the first province results in, cuts are not as deep as expected.
Labor shortages and higher salaries have led Shandong Weigao Group Medical Polymer Co. Ltd. to invest in automation as the firm plans to open three more dialysis centers.
SUZHOU, China - China's government is increasing medical expenditure dramatically to support its healthcare reforms and to ensure all citizens are covered by medical insurance by 2020